Sílvia Carvalho
Weizmann Institute of Science(IL)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Breast Cancer Treatment Studies, Cancer-related Molecular Pathways
Most-Cited Works
- → ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation(2015)667 cited
- → EGFR amplification and lack of activating mutations in metaplastic breast carcinomas(2006)262 cited
- → A reciprocal tensin-3–cten switch mediates EGF-driven mammary cell migration(2007)202 cited
- → Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis(2005)164 cited
- → LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer(2016)127 cited
- → EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy(2008)108 cited
- → Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression(2011)103 cited
- → Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment(2014)95 cited
- → EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer(2015)81 cited
- → Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer(2015)78 cited